Sold the rest 100k shares at $0.27. Bought 300k shares at $0.10 and had 270% gains. So sweet!
should be in jail. He deliberately destroyed the company. Someone should take action at the upcoming meeting. He is a prime example of corporate corruption and sociopathic tendencies. His lawyer friend Glen Sato is his loyal slave, refusing to allow shareholders to recoup any value.
Lets see how it all plays out. The 13d with the added wording about offers was odd but does let the cat out of the bag someone has been expressing interest. Who knows if other parties met the same fate but are now back in play. I will give them the benefit of the doubt that the phn or fax was inop or they only check the answering machine monthly. Im sure they are fighting hard for us and just caught up in prepping the conference room for 1 or 2 shareholders on vote day.
what options do we have?? Do you have the b$%$# and the resources to fight against these criminals? No!!,right??So shut up and stop with the paranoia!! At least Mr. Couchman is doing something!, otherwise we will be left with only a couple cents while these criminals get everything!!
I did lots of research on John Orwin. This is my conclusion: John Orwin had a strong relationship with Amgen before/during/after Omonty was introduced to the market. Omonty was a huge threat to Amgen's counterpart med. So, Amgen was determined to destroy Omonty from the market. As a result, Amgen talked to John Orwin to eliminate Omonty from the market and to give Orwin a CEO job, if he succeeded, at a very new company that Amgen funded. As John Orwin did eliminated Omonty from the market, he became CEO of Relypsa, a company Amgen funded. John Orwin is VERY unethical and incompetent. His action should be illegal.
I have made several references to the $6 million settlement mentioned in the derivative litigation documents on the Affymax website. I've asked anyone on this board to confirm by calling Lisa but no such luck so I called her this week. Apparently the $6 million is going to the class action litigation not the derivative litigation. We, the current Affymax shareholders, should be content to know that the BOD has promised to change the corporate governance. Of course that will never happen so the promise is bogus like the lawsuit. I believe that Judge Peter H. Kirwan's courtroom has been used in manipulating the stock. There are only a few days for current shareholders to voice the objections. After that I believe affy BOD is immune to sins you don't even know about yet.
While talking with Lisa about the NOLs she said the company did not want to spend between $40-$50k to have an analysis done. Lisa please correct me if I misquoted. That seems somewhat short sighted to me to forego possibly hundreds of millions to save $50 thousand. Maybe the Brenner Group could have answered the question being the restructuring experts that they are and they're already on the payroll.
Lisa's reply to communications received from Fresenius was that they are confidential and the board is not required to release them. I find that hard to believe. The fact that THE major consumer of your product has decided not to use it anymore would almost certainly be newsworthy enough to move the stock. When was the decision made? Feb.22,2013. And I can assure you many investors would not had they known that. Just look at how many investors dumped their shares after Affy's Feb.14,2013 filing of the Fresenius letter with the SEC.
Naji thank you again for the NEJM article you posted. More info came out of that than out of Affy.
Napa you asked "what options do we have?? Do you have the b$%$# and the resources to fight against these criminals?" My answer is don't become one. A criminal that is.
If that is all true, how does Takeda play a role? Would they let just one man ruin their entire investment? They too would have had to have some responsibility in the intentional downfall of the drug.